The 7th Annual Nordic American Life Science Conference
The most comprehensive gathering of Nordic life science innovation in the US, covering key company developments and trends from Norway, Sweden, Denmark, Finland and Iceland
The only event of its kind in the US, providing the largest US-Nordic forum in the US for life sciences, while at the same time being an intimate and highly curated gathering
Taking place over two days in New York City, the conference brings together leading Nordic biotechnology, medtech and healthtech companies and their investors for networking and connection opportunities with industry partners, innovation organizations, corporate development and investors
Hosted by DNB, Nasdaq and Business Sweden, with Back Bay Life Science Advisors and Innovation Norway, the conference is offered at no cost to our closest network of development peers – with the goal of fostering ongoing US-Nordic collaboration, investments and driving Nordic life science development forward
Presentations by leading Nordic biopharma, medtech and healthtech companies in areas with high patient need including oncology, cardiovascular, metabolic health, wound healing, and vaccines are scheduled
Expert panel discussions and workshops covering industry trends and challenges, including:
- Business challenges in new technologies (CAR T, microbiome, mRNA)
- Critical issues in digital healthcare development
- Impact of current public markets on life science deals
- Nordic equity valuations
- Alternative financing, partnering trends
For more information, please visit the Nordic American Life Science Conference website
